Axol Bioscience: Funding, Investors & Team (Sep 2026)
Axol specialize in human cell culture. Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers. These are iPSC-derived cells and the media and reagents required to successfully culture these cells. The company also do iPSC reprogramming and differentiation to various cell types as a service for customers that wish to use their own patient-derived samples. Axol is headquartered and maintains production on the Chesterford Research Park, a location renowned for inspiring innovation and success, located in Cambridge, UK.
Axol Bioscience has raised $12.3M across 3 funding rounds on record, the most recent an undisclosed round of $2.8M announced in Jan 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Axol Bioscience Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Axol Bioscience Funding Rounds
Axol Bioscience raised $5.3M in an undisclosed round announced in Mar 2021.
1.1 years later, an undisclosed round of $4.2M was announced in Apr 2022.
3.8 years later, an undisclosed round of $2.8M was announced in Jan 2026.
Axol Bioscience Founders and Leadership Team
Contact details for the Axol Bioscience team: 2 of 3 have an email address on file.
Start 14-day free trial →Axol Bioscience Funding Compared to Other Biotechnology Startups
Axol Bioscience's latest round of $2.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Axol Bioscience in Biotechnology and Cambridge
Companies Similar to Axol Bioscience
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Axol Bioscience Funding FAQs
What does Axol Bioscience do?
Axol specialize in human cell culture. Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers. These are iPSC-derived cells and the media and reagents required to successfully culture these cells. The company also do iPSC reprogramming and differentiation to various cell types as a service for customers that wish to use their own patient-derived samples. Axol is headquartered and maintains production on the Chesterford Research Park, a location renowned for inspiring innovation and success, located in Cambridge, UK.
How much funding has Axol Bioscience raised?
Axol Bioscience has raised $12.3M across 3 rounds on record. The most recent is an undisclosed round of $2.8M announced in Jan 2026.
When did Axol Bioscience last raise funding?
Axol Bioscience's most recent funding round on record is an undisclosed round of $2.8M, announced in Jan 2026.
Who founded Axol Bioscience?
FundedIQ lists Jonathan Milner (Founder) at Axol Bioscience.
Who is the CEO of Axol Bioscience?
Liam Taylor is listed as CEO at Axol Bioscience.
Where is Axol Bioscience headquartered?
Axol Bioscience is based in Cambridge, Massachusetts, United States.
How many employees does Axol Bioscience have?
Axol Bioscience is in the 11-50 employee band.
How does Axol Bioscience's funding compare to other Biotechnology startups?
Axol Bioscience's latest round of $2.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Axol Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Axol Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.